Federal saving from lowering of drug prices is unclear
New York Times, June 23, 2009
While The White House hailed what it described as a "historic agreement to lower drugs costs" for older Americans, it was not immediately clear how much the government would reap in savings that could be used to pay for coverage of the uninsured. As part of the agreement, pharmaceutical companies promised to help narrow a gap in Medicare coverage of prescription drugs that is known as the doughnut hole.
Most Viewed
Most Emailed
- 10 Major Changes to Health Reform in House's Reconciliation Bill
- Cardiology Group Fights Medicare Pay Cuts by Offering Concierge Services
- Primary Care is Unappealing to Many Medical Students
- Where Have All the CEOs Gone?
- Match Day a Reminder of Primary Care's Struggles
- Can 'Deadly Deliveries' Be a Wake-Up Call to Physicians, Hospitals?
- CBO: Latest Health Reform Bill Would Cost $940 Billion
- CEOs: Employee Retention Is Your Job
- Ten Ways to Increase Nurses' Time at the Bedside
- Benchmarking for Beleaguered Budgets
